Basri R, Fatima S, Jalil S, Imran A, Fatima N, Syed A, Bahkali AH, Iqbal J, Shafiq Z. 2-Oxoquinoline-based-thiosemicarbazones as multitargeting neurotherapeutics against Alzheimer's disease: In vitro and in silico studies of MAO and ChE inhibitors. Arch Pharm (Weinheim). 2023 Nov;356(11):e2300430. Epub 2023 Sep 17 PubMed.
Recommends
Please login to recommend the paper.
Comments
No Available Comments
Make a Comment
To make a comment you must login or register.